基本信息
文件名称：广泛耐药专家共识简版.ppt
文件大小：5.5 MB
总页数：38 页
更新时间：2020-08-16
总字数：约1.27千字
文档摘要
XDR共识指导临床实践 临床面临问题1、革兰阴性菌占临床分离的近3/4 阴盛阳衰” 临床分离菌中革兰阴性杆菌所占比例(%) CHINET 2013 772 73 革兰阳性菌 27% 68 1(22863/84572) 革兰阴性菌 (617984572) 200520062007200820092010201120122013 胡付品,中国感染与化疗杂志2014;145):2 临床面临问题2、革兰阴性菌耐药性严重 中国碳青霉烯类耐药克雷伯菌属(CRE) 显著上升趋势 CHINET Data 10.8 208 ■ Meropenem 8899.94 22.9 04600.3064 200520062007200820092010201120122013 3 临床面临问题2、革兰阴性菌耐药性严重 不动杆菌属对多数抗菌药的耐药率50% 12009■2010■2011■2012 CHIINET2009-2012 606161865646 676567 49■4949 10 Antimicrobia Urgent Threats ·耐药革兰阴性菌对 Clostridium diffic配e Carbapenem- reslstant Enterobacteriaceae(CR 临床造成严重威胁 Drug- resistant Neisseria gonorrhoeae Serious threats CRE被列为“紧急威 Multidrug-resistant Acinetobacter Drugresistant Campylobacter Fluconazole-resistant Candida (a fungus MDRAB. MDRPA Extended spectrum B-lactamase producing Enterobacteraceae(ESBLs 严重威胁 M此心m02 Drug-reslstant Non-typholdal salmonella Drug reslstant Salmonella Typhi Drug- resistant Shigella MethicllIn-reslstant Staphylococcus aureus(MRSAy lOTIC RESISTANCE THREATS( Drugresistant Streptococcus pneumoniae Drugresistant tuberculosis Concerning threats Vancomycin-resistant staphylococcus aureus (VRSA Erythromycin-resistant Group a streptococcus Clindamycin-reslstant Group B Streptococcus
XDR共识指导临床实践 临床面临问题1、革兰阴性菌占临床分离的近3/4 阴盛阳衰” 临床分离菌中革兰阴性杆菌所占比例(%) CHINET 2013 772 73 革兰阳性菌 27% 68 1(22863/84572) 革兰阴性菌 (617984572) 200520062007200820092010201120122013 胡付品,中国感染与化疗杂志2014;145):2 临床面临问题2、革兰阴性菌耐药性严重 中国碳青霉烯类耐药克雷伯菌属(CRE) 显著上升趋势 CHINET Data 10.8 208 ■ Meropenem 8899.94 22.9 04600.3064 200520062007200820092010201120122013 3 临床面临问题2、革兰阴性菌耐药性严重 不动杆菌属对多数抗菌药的耐药率50% 12009■2010■2011■2012 CHIINET2009-2012 606161865646 676567 49■4949 10 Antimicrobia Urgent Threats ·耐药革兰阴性菌对 Clostridium diffic配e Carbapenem- reslstant Enterobacteriaceae(CR 临床造成严重威胁 Drug- resistant Neisseria gonorrhoeae Serious threats CRE被列为“紧急威 Multidrug-resistant Acinetobacter Drugresistant Campylobacter Fluconazole-resistant Candida (a fungus MDRAB. MDRPA Extended spectrum B-lactamase producing Enterobacteraceae(ESBLs 严重威胁 M此心m02 Drug-reslstant Non-typholdal salmonella Drug reslstant Salmonella Typhi Drug- resistant Shigella MethicllIn-reslstant Staphylococcus aureus(MRSAy lOTIC RESISTANCE THREATS( Drugresistant Streptococcus pneumoniae Drugresistant tuberculosis Concerning threats Vancomycin-resistant staphylococcus aureus (VRSA Erythromycin-resistant Group a streptococcus Clindamycin-reslstant Group B Streptococcus